Prevalence of known diabetes in an urban Indian environment: the Darya Ganj diabetes survey

N P Verma, S P Mehta, S Madhu, H M Mather, H Keen
1986 BMJ (Clinical Research Edition)  
McCnkey B, Wright V. Comparison between pensciflamme and suphaslazine in rheumatoid arthritis: Leeds-Bimishm trial. BrMedJ 1983,27:1M9-102. 4 Pullar T, Hunter JA, Capell HA. Sulphlazine in eumatoid art:itit a double-Wblind comparison of sualne with placebo and sodium aurotiomalate. Br AMedJ ;f4A: 11024. S Bax DE, Amos RS. Suphasazine: a safe, effective agent for problged control of rheumatoid atitis. A coparison wih sodium aurothiomalate.4AsfRhea*sis 1985;44:194-8. 6 Martin t, Sitar DS,
more » ... IM, Hunter T7. iSulpsalase i vere rheumatoid arthrits: a study to assess potetil cormlaes of effiacy an toxicity. JRRAea 198S;12:270-3. 7 Bax DE, Amos RS, Situnayake D, McConkey B. Sulphasalazine in rheumatoid arthritis. Lances 198S;i:1450. 8 Pular T, Hunter JA, Capell HA. Suiphasline inrheumatoid arthritis. Laxcet l9S5 :1167. 9 Das KM, Estwood MA, McManus JPA, Sirius W. Adverse recwionduring salicylazosulphapyridine therapy and the relation with drug metbolism md setylator pheaotype. N EssgI_ Med 1983"23:491-5. 10 Pullar T, Hunter JA, Capell HA. Vhich component of sulphasabazie is active in rheimatoid arthritis?BrMedy 1985;29:1535-8. 11 Situnryake D, McConkey B. Resin-coated 5-aminoicyi acid (Asacol) in rheutoid Europeans. BrMedJ 1985;291:
doi:10.1136/bmj.293.6544.423 fatcat:nvskvukibbca3lg7iqklbkcg2a